LGD-4665

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLGD-4665
Drug Alias NameLGD-4665GSK-5291GSK-2285921
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThrombopoietin stimulants
TargetsThrombopoietin
Therapy Area/IndicationsPurpura, Thrombocytopenic, Idiopathic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPurpura, Thrombocytopenic, Idiopathic

Other Information

ATC CodeN/A
Related LinksN/A